EKSO BIONICS HOLDINGS, INC. (CHRN): debt financing — Ekso Bionics enters $2M secured loan with B. Riley at 10% interest

EKSO BIONICS HOLDINGS, INC.

Agreement with B. Riley Commercial Capital for up to $2.0M secured term loan, maturing Sept 14, 2026 or upon qualified equity raise of $2.4M.
Interest at 10% per annum; exit fee of $200K (10% of principal) due at maturity.
Loan may convert into equity in connection with a qualified financing at the lead investor's price.
Existing $2.0M loan from Banc of California (Pacific Western Bank) terminated and fully paid off.
Proceeds for working capital and general corporate purposes; secured by substantially all personal property of company and subsidiary.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

EKSO BIONICS HOLDINGS, INC. incurred term loan of $2.0 million with B. Riley Commercial Capital, LLC at 10.0% per annum maturing the earlier of the receipt of $2.4 million in net proceeds from the sale of the equity interests of the Company from new equity investors (a “Qualified Financin.

Instrument: term loan
Principal: $2.0 million
Counterparty: B. Riley Commercial Capital, LLC
Rate: 10.0% per annum
Maturity: the earlier of the receipt of $2.4 million in net proceeds from the sale of the equity interests of the Company from new equity investors (a “Qualified Financin
Event: incurrence

Exact text from the filing

On September 12, 2025, Ekso Bionics Holdings, Inc. (the “Company”) entered into a Secured Promissory Note and Security Agreement (the “Agreement”), by and among the Company, Ekso Bionics, Inc., a Delaware corporation and subsidiary of the Company (the “Subsidiary”), as guarantor, and B. Riley Commercial Capital, LLC, as lender (the “Lender”). The Agreement provides for a secured term loan in an aggregate principal amount of up to $2.0 million.

View on SEC.gov

41 debt financings filed in the last 30 days. Browse all debt financings →

EKSO BIONICS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-25-029285

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.